| |
Beardsworth is a
full-service CRO. We specialize in complicated trials
in difficult therapeutic areas. We are an
oncology niche provider. Beardsworth has recently conducted 50 oncology
and oncology-related clinical trials. While we specialize in oncology, we
have broad-based experience in other therapeutic areas, including
endocrinology, cardiovascular, immune response systems, dermatology and
infectious disease.
|
|
|
-
22 years - experienced, focused, stable. Beardsworth has been
supporting clinical drug development since 1986.
-
85% of our business comes from repeat clients
-
Our CRAs average 14 years of experience
-
Rescue trials are a key Beardsworth competency
|
| |
National Focus/Global Reach. While
our headquarters are conveniently situated in the heart of the Northeast
Corridor, we have a history of successful collaboration
with CRO partners around the world.
|
|
|
Michael J. O'Brien, President and CEO
Donna E Beardsworth, Chief Delivery Officer
Dan Diaz, Vice President of Business Development
Art Gertel, Vice
President of Clinical Services, Regulatory, and Medical Writing, will
be speaking at the following events:
April 29-May 3: EMWA Annual Conference, Barcelona, Spain
May 29-30: Global R&D Congress, Washington, DC
June 22-26: DIA Annual Meeting, Boston, MA
October 23-25: AMWA 68th Annual Conference, Louisville, KY
|
|
|
|
